These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1747015)

  • 1. Alterations in Alzheimer's disease-associated protein in Alzheimer's disease frontal and temporal cortex.
    Bissette G; Smith WH; Dole KC; Crain B; Ghanbari H; Miller B; Nemeroff CB
    Arch Gen Psychiatry; 1991 Nov; 48(11):1009-12. PubMed ID: 1747015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Demonstration of a specific profile of pathological Tau proteins in frontotemporal dementia cases].
    Vermersch P; Bordet R; Ledoze F; Ruchoux MM; Chapon F; Thomas P; Destée A; Lechevallier B; Delacourte A
    C R Acad Sci III; 1995 Apr; 318(4):439-45. PubMed ID: 7648357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ELISA-quantitation of phosphorylated tau protein in the Alzheimer's disease brain.
    Herrmann M; Golombowski S; Kräuchi K; Frey P; Mourton-Gilles C; Hulette C; Rosenberg C; Müller-Spahn F; Hock C
    Eur Neurol; 1999; 42(4):205-10. PubMed ID: 10567816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NGF content in the cerebral cortex of non-demented patients with amyloid-plaques and in symptomatic Alzheimer's disease.
    Hellweg R; Gericke CA; Jendroska K; Hartung HD; Cervós-Navarro J
    Int J Dev Neurosci; 1998; 16(7-8):787-94. PubMed ID: 10198825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased poly(ADP-ribosyl)ation of nuclear proteins in Alzheimer's disease.
    Love S; Barber R; Wilcock GK
    Brain; 1999 Feb; 122 ( Pt 2)():247-53. PubMed ID: 10071053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of Alzheimer's disease-associated protein (ADAP) in 10 human brains.
    Miller BE; Whetsell WO; Chong JK; Ghanbari HA
    J Neuropsychiatry Clin Neurosci; 1992; 4(3):303-7. PubMed ID: 1498582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications.
    Papasozomenos SC
    Lab Invest; 1989 Jan; 60(1):123-37. PubMed ID: 2492060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease.
    Buerger K; Ewers M; Pirttilä T; Zinkowski R; Alafuzoff I; Teipel SJ; DeBernardis J; Kerkman D; McCulloch C; Soininen H; Hampel H
    Brain; 2006 Nov; 129(Pt 11):3035-41. PubMed ID: 17012293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased tau accumulation in senile plaques as a hallmark in Alzheimer's disease.
    Shin RW; Ogomori K; Kitamoto T; Tateishi J
    Am J Pathol; 1989 Jun; 134(6):1365-71. PubMed ID: 2502927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).
    Bramblett GT; Trojanowski JQ; Lee VM
    Lab Invest; 1992 Feb; 66(2):212-22. PubMed ID: 1735956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clustering of Pick bodies in patients with Pick's disease.
    Armstrong RA; Cairns NJ; Lantos PL
    Neurosci Lett; 1998 Feb; 242(2):81-4. PubMed ID: 9533399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuritic pathology and dementia in Alzheimer's disease.
    McKee AC; Kosik KS; Kowall NW
    Ann Neurol; 1991 Aug; 30(2):156-65. PubMed ID: 1910274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The apolipoprotein E allele epsilon 4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease.
    Landén M; Thorsell A; Wallin A; Blennow K
    J Neurol Neurosurg Psychiatry; 1996 Oct; 61(4):352-6. PubMed ID: 8890772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-dimensional characterization of paired helical filament-tau from Alzheimer's disease: demonstration of an additional 74-kDa component and age-related biochemical modifications.
    Sergeant N; David JP; Goedert M; Jakes R; Vermersch P; Buée L; Lefranc D; Wattez A; Delacourte A
    J Neurochem; 1997 Aug; 69(2):834-44. PubMed ID: 9231745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical assay of Alzheimer's disease--associated protein(s) in human brain tissue. A clinical study.
    Ghanbari HA; Miller BE; Haigler HJ; Arato M; Bissette G; Davies P; Nemeroff CB; Perry EK; Perry R; Ravid R
    JAMA; 1990 Jun; 263(21):2907-10. PubMed ID: 2187102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease.
    Webster S; Lue LF; Brachova L; Tenner AJ; McGeer PL; Terai K; Walker DG; Bradt B; Cooper NR; Rogers J
    Neurobiol Aging; 1997; 18(4):415-21. PubMed ID: 9330973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olfactory response as a marker for Alzheimer's disease: Evidence from perceptual and frontal lobe oscillation coherence deficit.
    Sedghizadeh MJ; Hojjati H; Ezzatdoost K; Aghajan H; Vahabi Z; Tarighatnia H
    PLoS One; 2020; 15(12):e0243535. PubMed ID: 33320870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of regional glial fibrillary acidic protein levels in Alzheimer's disease.
    Ross GW; O'Callaghan JP; Sharp DS; Petrovitch H; Miller DB; Abbott RD; Nelson J; Launer LJ; Foley DJ; Burchfiel CM; Hardman J; White LR
    Acta Neurol Scand; 2003 May; 107(5):318-23. PubMed ID: 12713522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the novel protein P9TLDR (temporal lobe down-regulated) with a brain-site-specific gene expression modality in Alzheimer's disease brain.
    Yokota T; Akatsu H; Miyauchi T; Heese K
    FEBS Lett; 2012 Dec; 586(24):4357-61. PubMed ID: 23159938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined assessment of tau and neuronal thread protein in Alzheimer's disease CSF.
    Kahle PJ; Jakowec M; Teipel SJ; Hampel H; Petzinger GM; Di Monte DA; Silverberg GD; Möller HJ; Yesavage JA; Tinklenberg JR; Shooter EM; Murphy GM
    Neurology; 2000 Apr; 54(7):1498-504. PubMed ID: 10751266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.